Related Experiment Video
Updated: Oct 2, 2025

Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
New Insights on the Nuclear Functions and Targeting of FAK in Cancer
Silvia Pomella1, Matteo Cassandri1,2, Maria Rita Braghini3
1Department of Oncohematology, Bambino Gesù Children's Hospital, IRCCS, 00146 Rome, Italy.
Abstract:
Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase over-expressed and activated in both adult and pediatric cancers, where it plays important roles in the regulation of pathogenesis and progression of the malignant phenotype. FAK exerts its functions in cancer by two different ways: a kinase activity in the cytoplasm, mainly dependent on the integrin signaling, and a scaffolding activity into the nucleus by networking with different gene expression regulators. For this reason, FAK has to be considered a target with high therapeutic values. Indeed, evidence suggests that FAK targeting could be effective, either alone or in combination, with other already available treatments. Here, we propose an overview of the novel insights about FAK's structure and nuclear functions, with a special focus on the recent findings concerning the roles of this protein in cancer. Additionally, we provide a recent update on FAK inhibitors that are currently in clinical trials for patients with cancer, and discuss the challenge and future directions of drug-based anti-FAK targeted therapies.
Insights
Focal adhesion kinase (FAK) is crucial in cancer progression and presents a promising therapeutic target. Inhibitors targeting FAK are advancing in clinical trials for cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase.
- FAK is over-expressed and activated in various adult and pediatric cancers.
- It regulates cancer pathogenesis and malignant phenotype progression.
Purpose of the Study:
- To provide an overview of novel insights into FAK's structure and nuclear functions.
- To focus on recent findings regarding FAK's roles in cancer.
- To update on FAK inhibitors in clinical trials and discuss future therapeutic directions.
Main Methods:
- Literature review and synthesis of recent research findings.
- Analysis of FAK's dual role (cytoplasmic kinase and nuclear scaffolding).
- Examination of FAK's interaction with gene expression regulators.
Main Results:
- FAK exhibits both cytoplasmic kinase activity (integrin signaling) and nuclear scaffolding functions.
- FAK plays significant roles in cancer pathogenesis and progression.
- Several FAK inhibitors are currently undergoing clinical trials for cancer patients.
Conclusions:
- FAK is a validated therapeutic target for cancer due to its critical roles.
- Targeting FAK, alone or in combination, shows potential for effective cancer treatment.
- Further research into FAK inhibitors and targeted therapies is warranted.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Nuclear Protein Sorting
Proteins targeted to the nucleus carry nuclear localization signals or NLS recognized by import receptors in the cytosol. Similarly, proteins with nuclear export signals are recognized by export receptors. Import and export receptors are...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of Nuclear Protein Sorting
![Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F68356.jpg&w=3840&q=50)
![An Automated Radiosynthesis of [68Ga]Ga-FAPI-46 for Routine Clinical Use](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F66708.jpg&w=3840&q=50)